VINC logo

Vincerx Pharma (VINC) Cash From Operations

Annual CFO

-$40.45 M
+$19.15 M+32.13%

December 31, 2023


Summary


Performance

VINC Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVINCcash flowmetrics:

Quarterly CFO

-$6.38 M
-$551.00 K-9.45%

September 30, 2024


Summary


Performance

VINC Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVINCcash flowmetrics:

TTM CFO

-$27.96 M
+$266.00 K+0.94%

September 30, 2024


Summary


Performance

VINC TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVINCcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

VINC Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+32.1%+20.4%+30.9%
3 y3 years-1675.0%+57.5%+37.9%
5 y5 years---

VINC Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-21.1%+32.1%-9.4%+59.9%at high+53.1%
5 y5-year-1675.0%+32.1%<-9999.0%+59.9%<-9999.0%+53.1%
alltimeall time-1675.0%+32.1%<-9999.0%+59.9%<-9999.0%+53.1%

Vincerx Pharma Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$6.38 M(+9.5%)
-$27.96 M(-0.9%)
Jun 2024
-
-$5.83 M(-24.7%)
-$28.23 M(-19.6%)
Mar 2024
-
-$7.74 M(-3.5%)
-$35.10 M(-13.2%)
Dec 2023
-$40.45 M(-32.1%)
-$8.02 M(+20.7%)
-$40.45 M(-12.5%)
Sep 2023
-
-$6.64 M(-47.7%)
-$46.25 M(-15.1%)
Jun 2023
-
-$12.70 M(-3.0%)
-$54.48 M(-5.5%)
Mar 2023
-
-$13.09 M(-5.2%)
-$57.67 M(-3.2%)
Dec 2022
-$59.60 M
-$13.82 M(-7.1%)
-$59.60 M(+4.1%)
Sep 2022
-
-$14.87 M(-6.4%)
-$57.27 M(+8.7%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$15.89 M(+5.7%)
-$52.70 M(+17.1%)
Mar 2022
-
-$15.03 M(+30.8%)
-$44.99 M(+34.7%)
Dec 2021
-$33.40 M(+1365.6%)
-$11.49 M(+11.5%)
-$33.40 M(+38.9%)
Sep 2021
-
-$10.30 M(+26.0%)
-$24.05 M(+73.1%)
Jun 2021
-
-$8.18 M(+137.9%)
-$13.89 M(+143.0%)
Mar 2021
-
-$3.44 M(+61.0%)
-$5.72 M(+150.8%)
Dec 2020
-$2.28 M
-$2.13 M(+1382.6%)
-$2.28 M(+1482.6%)
Sep 2020
-
-$144.00 K(<-9900.0%)
-$144.00 K(<-9900.0%)
Jun 2020
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2020
-
$0.00
$0.00

FAQ

  • What is Vincerx Pharma annual cash flow from operations?
  • What is the all time high annual CFO for Vincerx Pharma?
  • What is Vincerx Pharma annual CFO year-on-year change?
  • What is Vincerx Pharma quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Vincerx Pharma?
  • What is Vincerx Pharma quarterly CFO year-on-year change?
  • What is Vincerx Pharma TTM cash flow from operations?
  • What is the all time high TTM CFO for Vincerx Pharma?
  • What is Vincerx Pharma TTM CFO year-on-year change?

What is Vincerx Pharma annual cash flow from operations?

The current annual CFO of VINC is -$40.45 M

What is the all time high annual CFO for Vincerx Pharma?

Vincerx Pharma all-time high annual cash flow from operations is -$2.28 M

What is Vincerx Pharma annual CFO year-on-year change?

Over the past year, VINC annual cash flow from operations has changed by +$19.15 M (+32.13%)

What is Vincerx Pharma quarterly cash flow from operations?

The current quarterly CFO of VINC is -$6.38 M

What is the all time high quarterly CFO for Vincerx Pharma?

Vincerx Pharma all-time high quarterly cash flow from operations is $0.00

What is Vincerx Pharma quarterly CFO year-on-year change?

Over the past year, VINC quarterly cash flow from operations has changed by +$1.64 M (+20.45%)

What is Vincerx Pharma TTM cash flow from operations?

The current TTM CFO of VINC is -$27.96 M

What is the all time high TTM CFO for Vincerx Pharma?

Vincerx Pharma all-time high TTM cash flow from operations is $0.00

What is Vincerx Pharma TTM CFO year-on-year change?

Over the past year, VINC TTM cash flow from operations has changed by +$12.49 M (+30.87%)